This inventor holds 1 USPTO granted patent. Top assignee: Athera Biotechnologies Ab. Active years: 2004.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2004
Title: Johan Frostegård: Innovator in Cardiovascular Diagnostics
Introduction
Johan Frostegård is a notable inventor based in Nacka, Sweden. He has made significant contributions to the field of medical diagnostics, particularly in cardiovascular health. His innovative approach has the potential to improve early detection and treatment of cardiovascular diseases.
Latest Patents
Frostegård holds a patent for a method of diagnosing cardiovascular disease and early atherosclerosis. This invention provides a method for assessing the presence and/or concentration of antibodies to platelet activating factor (PAF) in a sample of body fluid. The method aims to identify individuals at increased risk of cardiovascular issues, thereby facilitating timely medical intervention. Additionally, the invention includes a kit designed to carry out this diagnostic method. He has 1 patent to his name.
Career Highlights
Johan Frostegård is associated with Athera Biotechnologies AB, a company focused on developing innovative solutions for cardiovascular health. His work at Athera has been instrumental in advancing research and applications in the field of diagnostics.
Collaborations
Due to space constraints, the collaborations section has been omitted.
Conclusion
Johan Frostegård's contributions to cardiovascular diagnostics exemplify the impact of innovation in healthcare. His work not only enhances our understanding of cardiovascular diseases but also paves the way for improved diagnostic methods.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile